Altria Group Total Cost of Revenue decreased by 13.5% to $1.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $1.27B to $1.25B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -5.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.88B | $1.86B | $1.77B | $1.45B | $1.71B | $1.72B | $1.57B | $1.43B | $1.68B | $1.58B | $1.53B | $1.44B | $1.60B | $1.54B | $1.50B | $1.27B | $1.44B | $1.44B | $1.45B | $1.25B |
| QoQ Change | — | -1.3% | -4.7% | -18.4% | +18.1% | +0.4% | -8.3% | -8.8% | +17.2% | -6.1% | -3.4% | -5.8% | +11.5% | -4.1% | -2.2% | -15.4% | +13.4% | -0.1% | +0.6% | -13.5% |
| YoY Change | — | — | — | — | -9.2% | -7.7% | -11.2% | -0.8% | -1.6% | -8.0% | -3.1% | +0.2% | -4.7% | -2.7% | -1.5% | -11.6% | -10.1% | -6.3% | -3.6% | -1.4% |